MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $173,026,000 | -21.7% | 787,772 | -40.8% | 0.16% | -65.5% |
| Q3 2020 | $220,963,000 | -10.8% | 1,330,702 | -38.6% | 0.48% | -20.2% |
| Q2 2020 | $247,586,000 | +43.3% | 2,168,572 | -3.5% | 0.60% | +4.0% |
| Q1 2020 | $172,804,000 | -25.6% | 2,248,009 | +24.8% | 0.58% | -14.5% |
| Q4 2019 | $232,172,000 | +123.9% | 1,801,740 | +35.4% | 0.67% | +102.4% |
| Q3 2019 | $103,697,000 | -27.0% | 1,330,983 | -3.5% | 0.33% | -21.3% |
| Q2 2019 | $142,100,000 | – | 1,379,614 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |